We are live on ! Find out more
ADIL

Adial Pharmaceuticals
ADIL

13 hedge funds and large institutions have $233K invested in Adial Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

0.44% less ownership

Funds ownership: 0.87% → 0.42% (-0.44%)

7% less funds holding

Funds holding: 14 → 13 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

53% less capital invested

Capital invested by funds: $491K → $233K (-$258K)

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$53.6K
2
Renaissance Technologies
Renaissance Technologies
New York
+$41.8K
3
VF
Virtu Financial
New York
+$30.7K
4
UBS Group
UBS Group
Switzerland
+$3.14K
5
Osaic Holdings
Osaic Holdings
Arizona
+$2.81K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$296K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$27.5K
3
JP Morgan Chase
JP Morgan Chase
New York
-$4.65K
4
FWM
Focused Wealth Management
New York
-$1.02K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$37
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$68K +$41.8K +1,116 +120%
MCM
2
Manchester Capital Management
Vermont
$64K – – –
HF
3
HRT Financial
New York
$47K +$53.6K +1,431 New
VF
4
Virtu Financial
New York
$27K +$30.7K +819 New
BlackRock
5
BlackRock
New York
$10.2K – – –
UBS Group
6
UBS Group
Switzerland
$7.62K +$3.14K +84 +58%
TRCT
7
Tower Research Capital (TRC)
New York
$6.15K +$599 +16 +9%
Osaic Holdings
8
Osaic Holdings
Arizona
$3.33K +$2.81K +75 +300%
HT
9
Headlands Technologies
Illinois
$85 +$112 +3 New
AWM
10
Abound Wealth Management
Tennessee
$36 – – –
Morgan Stanley
11
Morgan Stanley
New York
$20 – – –
Wells Fargo
12
Wells Fargo
California
$15 – – –
Qube Research & Technologies (QRT)
13
Qube Research & Technologies (QRT)
United Kingdom
$11 – – –
AC
14
Armistice Capital
New York
– -$296K -6,360 Closed
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
– -$27.5K -592 Closed
JP Morgan Chase
16
JP Morgan Chase
New York
– -$4.65K -100 Closed
FWM
17
Focused Wealth Management
New York
– -$1.02K -22 Closed
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
– -$37 -1 -50%

ADIL Hedge Fund Activity: Q1 2024 in Review

13 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q1 2024, worth a combined $233K — down 53% from $491K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ADIL and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.

The largest buyer was HRT Financial, opening a new position worth an estimated $53.6K. The largest seller was Armistice Capital, exiting entirely with an estimated $296K sold.

  • 13 institutional investors held Adial Pharmaceuticals (ADIL) as of Q1 2024, down from 14 in Q4 2023.
  • Funds reported $233K of Adial Pharmaceuticals stock for Q1 2024, down 53% quarter-over-quarter.
  • 3 funds opened new Adial Pharmaceuticals positions in Q1 2024 and 4 closed out, a net change of -1 holder.
  • The largest Adial Pharmaceuticals buyer in Q1 2024 was HRT Financial, an estimated $53.6K added.
  • The largest Adial Pharmaceuticals seller in Q1 2024 was Armistice Capital, an estimated $296K sold.

Based on aggregated 13F filings for Q1 2024.